QuanMol Tech has been named as one of the awardees for the 2022 BigBang Innovation Competition hosted by L’Oréal with a project that using QuanMol Tech’s unique ability of molecular simulation to predict organic compound’s optical properties. The BigBang aims to help L’Oréal better connect with startup companies that using advanced technologies to facilitate makeup industry development.

SAN FRANCISCO BAY AREA, CA – QuanMol Tech, Inc., a pioneering AI technology startup focused on bioactive small molecule discovery, proudly announces its entrance into the esteemed NVIDIA Inception program. Recognized for its commitment to technological innovation, the program is designed to support startups driving advancements across various industries.

Commencing the new year in 2023, Pharmacodia and QuanMol Tech together announced their strategic partnership agreement. This collaboration is grounded in their substantial resources in innovative drug R&D and the technological prowess of their platforms. Capitalizing on the potential inherent in AI and big data in drug development, the partners aim to synergize AI-driven designs for novel drug molecular structures and software systems optimizing drug properties. This strategic partnership, enriched by expert insights, seeks to catalyze advancements in the early stages of innovative drug discovery with the overarching objective of expediting the maturation of AI within the pharmaceutical domain and augmenting the success rates of drug development endeavors. 

QuanMol Tech closes its Seed Fundraising in early Nov. 2022. The funding will advance QuanMol Redefine, a platform enabled by edge cutting technologies to help experimentalists interpret data and boost the efficiency for chemical product development.